Latest Asset Sales News

Assetora Limited has obtained a Supreme Court injunction restraining external receivers, allowing its directors to maintain control while agreeing on payments to noteholders.

Triton Minerals reports encouraging geological signs from its maiden drilling at the Aucu Gold-Copper Project despite operational hurdles, while legal delays stall the completion of its 70% graphite asset sale.

Epsilon Healthcare Limited has unveiled a comprehensive pre-reinstatement disclosure, highlighting improved financial health and a strategic growth plan focused on operational stability and expansion.

HealthCo Healthcare & Wellness REIT confirms full rent payment from Healthscope and has conditional agreements with alternative tenants for its hospital portfolio, while suspending its December quarter distribution to preserve liquidity.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

Marvel Gold Limited has agreed to sell its Yanfolila Gold Project in Mali to Askiya Mineral Resources for up to US$1.94 million, marking a strategic shift to focus on its Tanzanian assets.

Treasury Wine Estates moderates its first-half fiscal 2026 outlook due to softer US and China markets, unveiling a major transformation program targeting $100 million in annual cost savings starting next year.

Treasury Wine Estates moderates growth forecasts due to softening demand in key US and China markets, unveiling a major transformation program and cost-saving measures to safeguard brand strength and profitability.

Epsilon Healthcare reported a 19% revenue increase to $3.4 million for the half year ended June 2025, driven by new client wins and its pharmacy segment launch. However, net losses widened 44% to $2.07 million, reflecting administration and financing costs during its recovery phase.

InhaleRx advances its clinical pipeline with a new oral treatment for resistant depression and plans a strategic rebrand to Nexalis Therapeutics, signaling a broader focus beyond inhaled therapies.

Moho Resources has sold its Silver Swan North Project to Mineral Mining Services, boosting funds for its maiden drilling program at the promising Bush Chook Project in Western Australia’s Pilbara region.

OM Holdings has cleared major regulatory hurdles in the $101 million sale of its 26% stake in Ntsimbintle Mining, moving closer to closing the deal in early 2026.